Prioritising respiratory syncytial virus prevention in low-income and middle-income countries

著者: Xavier Carbonell‐Estrany, Eric A. F. Simões, Louis Bont, Bosco Paes, Xavier Carbonell‐Estrany, Eric A. F. Simões, Louis Bont, Bosco Paes, Adaeze C. Ayuk, Ángela Gentile, Anne Greenough, Antonio Moreno, Arun Kumar Sharma, Asunción Mejías, Barry Rodgers‐Gray, Bernhard Resch, Brigette Fauroux, Carlos E. Rodríguez‐Martínez, Chadi El Saleeby, W. Charles Huskins, Cheryl Cohen, David A. Greenberg, Eugenio Baraldi, Evan J. Anderson, Federico Martinón‐Torres, Fernando F Polack, Giovanni Piedimonte, Harish Nair, Hayley A. Gans, Heather J. Zar, Hiroyuki Moriuchi, Hitoshi Oshitani, Ian Mitchell, D. James Nokes, Sheikh Jarju, Jeffrey M. Pernica, Jesse Papenburg, Joan Robinson, Joanne de Jesus-Cornejo, Joanne M. Langley, Johannes G. Liese, Jose Figueras Aloy, Juan Pablo Torres, Kathryn M. Edwards, Leonard R. Krilov, Maduja Divaratne, Manuel Sánchez Luna, Marcello Lanari, Marcelo Comerlato Scottá, Maria Ahuoiza Garba, M. Mori, Merih Çetınkaya, Mitchell Goldstein, Najwa Khuri‐Bulos, Néstor Vain, Nikolaos G. Papadopoulus, Nusrat Homaira, Octavio Ramilo, Paolo Manzoni, Patrick K. Munywoki, Pedro A. Piedra, Peter P. Moschovis, Peter Openshaw, Quique Bassat, Renato T. Stein, Rik Thwaites, Rohitha Muthugala, Rolando Ulloa‐Gutiérrez, Ron Dagan, Rosa Rodríguez Fernández, Satoshi Kusuda, Shabir A. Madhi, Shobha Broor, Simon B. Drysdale, Sudha Basnet, Terho Heikkinen, Vasanthi Avadhanula, Xavier Sáez‐Llorens, Xin Wang, You Li, Joseph L. Mathew - The Lancet 2023 被引用: 26

Respiratory syncytial virus is a major cause of lower respiratory tract infection morbidity and mortality in children globally, causing 3·2–3·6 million hospitalisations and more than 100 000 deaths annually in children younger than 5 years, 99% of which occur in low-income and middle-income countries (LMICs).1 Despite being identified 65 years ago, at the same time as poliovirus, there is no widely available and affordable preventive strategy for respiratory syncytial virus.